A class of benzopyran derivatives is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula (I'), wherein X, A<1>, A<2>, A<3>, A<4>, R, R", R<1> and R<2> are as described in the specification.